Literature DB >> 29987374

Pediatric neurocysticercosis.

Ricardo Santos de Oliveira1, Dinark Conceição Viana1, Benedicto Oscar Colli1, Vedantam Rajshekhar2, José Francisco Manganelli Salomão3.   

Abstract

BACKGROUND: Neurocysticercosis (NCC) is an infestation of the nervous system caused by encysted larvae of Taenia solium. NCC is an important acquired cause of epilepsy and other neurological manifestations especially in endemic areas. NCC in children has pleomorphic manifestations depending on the location, number, viability of the cysts, and host response. Even with advancing knowledge of the disease manifestations, many aspects related to diagnosis and treatment, particularly in children, still remain controversial and pose challenges to clinical practice. There is no gold standard test to diagnose NCC and the management recommendations are still emerging. This review provides an overview of diagnosis of NCC in children and its management with special focus on current challenges and future prospects. DISCUSSION: In developing countries, NCC is important not only because of its frequency but also because of high morbidity and mortality rates associated, especially in cases in which it progresses to increased intracranial pressure. Because of its pleomorphic presentation, NCC should be considered in the differential diagnosis of a number of neurological conditions. Treatment with cysticidal therapy leads to reduction in seizure frequency and a faster resolution of lesions.
CONCLUSIONS: We have summarized the current approaches to diagnosis and treatment of NCC, recent advances in understanding the biology of NCC, and how one can take advantage of these new insights to formulate the next generation of clinical trials.

Entities:  

Keywords:  Brain; Cysticercosis; Epilepsy; Hydrocephalus; Intracranial hypertension; Parasitic disease; Parenchymal cyst

Mesh:

Year:  2018        PMID: 29987374     DOI: 10.1007/s00381-018-3889-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  36 in total

1.  Enzyme linked immunosorbent assay (ELISA) for the detection of IgG, IgM, IgE and IgA against Cysticercus cellulosae in cerebrospinal fluid of patients with neurocysticercosis.

Authors:  Newton Satoru Odashima; Osvaldo Massaiti Takayanagui; José Fernando de Castro Figueiredo
Journal:  Arq Neuropsiquiatr       Date:  2002-06       Impact factor: 1.420

2.  Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures.

Authors:  V Rajshekhar; M J Chandy
Journal:  Acta Neurol Scand       Date:  1997-08       Impact factor: 3.209

Review 3.  Neurocysticercosis.

Authors:  Pratibha Singhi; Renu Suthar
Journal:  Indian J Pediatr       Date:  2014-10-10       Impact factor: 1.967

4.  Spinal cord cysticercosis: neurosurgical aspects.

Authors:  Benedito Oscar Colli; Marcelo Moraes Valença; Carlos Gilberto Carlotti; Helio Rubens Machado; João Alberto Assirati
Journal:  Neurosurg Focus       Date:  2002-06-15       Impact factor: 4.047

Review 5.  Revised diagnostic criteria for neurocysticercosis.

Authors:  O H Del Brutto; T E Nash; A C White; V Rajshekhar; P P Wilkins; G Singh; C M Vasquez; P Salgado; R H Gilman; H H Garcia
Journal:  J Neurol Sci       Date:  2016-11-21       Impact factor: 3.181

6.  Conformation-sensitive immunoassays improve the serodiagnosis of solitary cysticercus granuloma in Indian patients.

Authors:  Vasudevan Prabhakaran; Vedantam Rajshekhar; Kenneth Darwin Murrell; Anna Oommen
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-12-13       Impact factor: 2.184

Review 7.  Current consensus guidelines for treatment of neurocysticercosis.

Authors:  Hector H García; Carlton A W Evans; Theodore E Nash; Osvaldo M Takayanagui; A Clinton White; David Botero; Vedantam Rajshekhar; Victor C W Tsang; Peter M Schantz; James C Allan; Ana Flisser; Dolores Correa; Elsa Sarti; Jon S Friedland; S Manuel Martinez; Armando E Gonzalez; Robert H Gilman; Oscar H Del Brutto
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 8.  Surgical management of neurocysticercosis.

Authors:  Vedantam Rajshekhar
Journal:  Int J Surg       Date:  2010-01-04       Impact factor: 6.071

9.  Pediatric neurocysticercosis: usefulness of antibody response in cysticidal treatment follow-up.

Authors:  Venkata Subba Rao Atluri; Venkateswara Reddy Gogulamudi; Pratibha Singhi; Niranjan Khandelwal; Lakshmana Swamy Parasa; Nancy Malla
Journal:  Biomed Res Int       Date:  2014-08-06       Impact factor: 3.411

Review 10.  Pediatric neurocysticercosis: current challenges and future prospects.

Authors:  Pratibha Singhi; Arushi Gahlot Saini
Journal:  Pediatric Health Med Ther       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.